Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel
NCT00159003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2017-08-10
Summary
There are naturally occuring variations in the genetic makeup of all of us. Some of these variations may contribute to a change in susceptibility toward different diseases or change the prognosis.
We are studying these genetic variations in patients with leukemia. The genes we are studying are those which influence detoxification of drugs and toxins.
Conditions
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
Sponsors & Collaborators
-
Deborah Rund
lead OTHER
Principal Investigators
-
Deborah G Rund, MD · Hadassah Medical Organization
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-01-01
- Primary Completion
- 2017-07-01
- Completion
- 2017-07-01
Countries
- Israel
Study Locations
More Related Trials
-
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
NCT06543511 ·Status: WITHDRAWN ·Phase: NA
-
A Model for Genetic Susceptibility: Melanoma
NCT00591500 ·Status: ACTIVE_NOT_RECRUITING
-
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
NCT00450593 ·Status: UNKNOWN
-
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
NCT01653613 ·Status: UNKNOWN
-
Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
NCT00581750 ·Status: COMPLETED
-
Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
NCT05837884 ·Status: RECRUITING
-
Clinical Outcomes in Hereditary Cancer
NCT00580021 ·Status: WITHDRAWN
-
Pancreatic Cancer Genetics
NCT01102569 ·Status: RECRUITING
-
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer
NCT02560818 ·Status: COMPLETED ·Phase: NA
-
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
NCT04920513 ·Status: COMPLETED
-
Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian Cancer
NCT00855998 ·Status: UNKNOWN
-
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
NCT01500499 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts
NCT04657679 ·Status: TERMINATED ·Phase: PHASE4
-
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 ·Status: RECRUITING
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members
NCT00346008 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder
NCT01511575 ·Status: COMPLETED
-
Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia
NCT01139333 ·Status: COMPLETED
-
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
NCT01143519 ·Status: COMPLETED
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
NCT01119586 ·Status: COMPLETED
-
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
NCT03922893 ·Status: RECRUITING
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED